Aspen Neuroscience, Inc. Common Stock

ASPE

Börsenwert 433 Mio. $

14,89 USD

0,00

0 %

1 Tag

0 %

5 Tage

1,29 %

1 Monat

0 %

3 Monate

0 %

6 Monate

0 %

Seit Jahresbeginn

0 %

1 Jahr

0 %

5 Jahre

0 %

10 Jahre

0 %

Profil: Aspen Neuroscience Inc is a clinical-stage, regenerative medicine biotechnology company focused on developing autologous induced-pluripotent stem cell (iPSC)-derived therapies to initially address neurodegenerative diseases with high unmet medical need. The company's flagship program, sasineprocel, is an investigational autologous iPSC-based therapy for Parkinson's disease designed to replace a patient's lost dopamine neurons with dopaminergic neuron precursor cells.

Gesundheitswesen Biotechnologie